Addiction Science & Clinical Practice is affiliated with the International Network on Brief Interventions for Alcohol & Other Drugs.
Articles
Page 4 of 17
-
Citation: Addiction Science & Clinical Practice 2022 17(Suppl 1):33
-
Expanding access to medications for opioid use disorder through locally-initiated implementation
Despite demonstrated efficacy, medication treatment for opioid use disorder (MOUD) remain inaccessible to many patients, with barriers identified at the individual, clinic and system level. A wide array of imp...
Citation: Addiction Science & Clinical Practice 2022 17:32 -
A mobile-based pregaming drinking prevention intervention for college students: study protocol for a randomized controlled trial
Pregaming is a high-drink context popular among college students that often leads to elevated blood alcohol levels and negative consequences. Over 15 years of research studies have demonstrated that pregaming ...
Citation: Addiction Science & Clinical Practice 2022 17:31 -
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative
Until recently, few carceral facilities offered medications for opioid use disorder (MOUD). Although more facilities are adopting MOUD, much remains to be learned about addressing implementation challenges rel...
Citation: Addiction Science & Clinical Practice 2022 17:30 -
Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program
A cessation program for hospitalized smokers is an effective strategy to achieve smoking abstinence. The effects of multiple in-hospital counseling sessions on 6-month smoking abstinence require further invest...
Citation: Addiction Science & Clinical Practice 2022 17:29 -
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial
The 2016 U.S. Centers for Disease Control Opioid Prescribing Guideline (CDC Guideline) is currently being revised amid concern that it may be harmful to people with chronic pain on long-term opioid therapy (CP...
Citation: Addiction Science & Clinical Practice 2022 17:28 -
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions
Subcutaneously retained needle fragments in people who inject drugs (PWIDs) are a possible cause of local symptoms, most commonly pain and infections. It remains unknown how common retained needle fragments ar...
Citation: Addiction Science & Clinical Practice 2022 17:27 -
Feasibility of a computer-assisted social network motivational interviewing intervention to reduce substance use and increase supportive connections among emerging adults transitioning from homelessness to housing
Social networks may play positive and negative roles in the lives of young adults experiencing homelessness (YEH) who are transitioning into housing. Social networks can influence their alcohol and/or other dr...
Citation: Addiction Science & Clinical Practice 2022 17:26 -
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis
Drug overdose rates in the United States have been steadily increasing, particularly in rural areas. The COVID-19 pandemic and associated mitigation strategies may have increased overdose risk for people who u...
Citation: Addiction Science & Clinical Practice 2022 17:24 -
Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): process of adapting collaborative care for co-occurring opioid use and mental disorders
Opioid use disorders (OUD), co-occurring with either depression and/or PTSD, are prevalent, burdensome, and often receive little or low-quality care. Collaborative care is a service delivery intervention that ...
Citation: Addiction Science & Clinical Practice 2022 17:25 -
More than three times as many Indigenous Australian clients at risk from drinking could be supported if clinicians used AUDIT-C instead of unstructured assessments
Aboriginal and Torres Strait Islander (‘Indigenous’) Australians experience a greater burden of disease from alcohol consumption than non-Indigenous peoples. Brief interventions can help people reduce their co...
Citation: Addiction Science & Clinical Practice 2022 17:23 -
Case report: acute care management of severe opioid withdrawal with IV fentanyl
An increasing number of individuals who use drugs in North America are preferentially consuming fentanyl over other opioids. This has significant consequences on the treatment and management of opioid use diso...
Citation: Addiction Science & Clinical Practice 2022 17:22 -
Correction to: A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program
Citation: Addiction Science & Clinical Practice 2022 17:21 -
Automated Reinforcement Management System (ARMS): focused phase I provider feedback
Alcohol use increases risk for morbidity and mortality and is associated with over 3 million annual deaths worldwide. Contingency Management (CM) is one of the most effective interventions for substance use di...
Citation: Addiction Science & Clinical Practice 2022 17:20 -
Using practice facilitation to improve alcohol-related care in primary care: a mixed-methods pilot study protocol
Alcohol use is a significant risk factor for disability and death in U.S. adults, and approximately one out of every six Veterans seen in primary care (PC) report unhealthy alcohol use. Unhealthy alcohol use i...
Citation: Addiction Science & Clinical Practice 2022 17:19 -
Using intervention mapping for hookah smoking cessation: a quasi-experimental evaluation
The present study aimed to evaluate the results of a theory-based and systematic intervention on Hookah Tobacco Smoking (HTS) cessation in women local to Bandar Abbas, Iran.
Citation: Addiction Science & Clinical Practice 2022 17:18 -
‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians
Disadvantage and transgenerational trauma contribute to Aboriginal and Torres Strait Islander (Indigenous) Australians being more likely to experience adverse health consequences from alcohol and other drug us...
Citation: Addiction Science & Clinical Practice 2022 17:17 -
Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown
Morbidity and mortality related to opioid use disorder (OUD) in the U.S. is at an all-time high. Innovative approaches are needed to address gaps in retention in treatment with medications for opioid use disor...
Citation: Addiction Science & Clinical Practice 2022 17:16 -
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community
Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death. Few persons who ...
Citation: Addiction Science & Clinical Practice 2022 17:15 -
Therapeutic community-oriented day treatment program for Korean women with alcohol use disorder: a non-randomized pilot feasibility trial
The prevalence of alcohol use disorder (AUD) among women in South Korea has been rising, causing public health problems. Yet women’s treatment needs are mostly unmet in South Korea due to the lack of women-foc...
Citation: Addiction Science & Clinical Practice 2022 17:14 -
Effects of service-wide support on regularity of alcohol screening of clients in Australian Aboriginal and Torres Strait Islander Community Controlled Health Services: a cluster randomised trial
We have previously shown that service-wide support can increase the odds of alcohol screening in any 2-month period in a cluster randomized trial of service-wide support to Aboriginal and Torres Strait Islande...
Citation: Addiction Science & Clinical Practice 2022 17:13 -
Shifts at The Helm: gratitude, re-commitment to our work, and a call for addictions disparities research
Citation: Addiction Science & Clinical Practice 2022 17:12 -
A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program
The cervical cancer burden is high among women living in Appalachia. Cigarette smoking, a cervical cancer risk factor, is also highly prevalent in this population. This project aims to increase smoking cessati...
Citation: Addiction Science & Clinical Practice 2022 17:11 -
Patient and provider perspectives on self-administered electronic substance use and mental health screening in HIV primary care
Substance use disorders, depression and anxiety disproportionately affect people with HIV (PWH) and lead to increased morbidity and mortality. Routine screening can help address these problems but is underutil...
Citation: Addiction Science & Clinical Practice 2022 17:10 -
Clinicians’ perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis
Alcohol use disorder (AUD) is one of the leading etiologies for liver cirrhosis and liver transplantation. Few individuals with AUD receive guideline-based care in the form of screening, brief intervention, re...
Citation: Addiction Science & Clinical Practice 2022 17:9 -
Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa
Interventions are needed to improve the quality of South Africa’s substance use disorder (SUD) treatment system. This study aimed to identify factors associated with patient-reported suboptimal access, quality...
Citation: Addiction Science & Clinical Practice 2022 17:8 -
Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum—20 years of research informing practice
Citation: Addiction Science & Clinical Practice 2022 17:7 -
Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans
To address the US opioid epidemic, there is an urgent clinical need to provide persons with opioid use disorder (OUD) with effective medication treatments for OUD (MOUD). Formulations of sublingual buprenorphi...
Citation: Addiction Science & Clinical Practice 2022 17:6 -
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018
Medications to treat opioid use disorder (OUD) including buprenorphine products are evidence-based and cost-effective tools for combating the opioid crisis. However, limited availability to buprenorphine is pe...
Citation: Addiction Science & Clinical Practice 2022 17:5 -
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study
Extended-release buprenorphine (XRB) offers a novel approach to sustained monthly treatment for people who use opioids in criminal justice settings (CJS). This study explores the experiences of adults receivin...
Citation: Addiction Science & Clinical Practice 2022 17:4 -
Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy
A quarter of pregnant women use alcohol, 6.5/1000 deliveries are affected by opioid use disorder (OUD), and the prevalence of cannabis use in pregnant women is increasing. However, marijuana co-exposure in pol...
Citation: Addiction Science & Clinical Practice 2022 17:3 -
Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial
Smoking cessation is the most effective means of slowing the decline of lung function associated with chronic obstructive pulmonary disease (COPD). While effective smoking cessation treatments are available, t...
Citation: Addiction Science & Clinical Practice 2022 17:2 -
A personalized biomedical risk assessment infographic for people who smoke with COPD: a qualitative study
Chronic obstructive pulmonary disease (COPD) causes 3 million deaths each year, yet 38% of COPD patients continue to smoke. Despite proof of effectiveness and universal guideline recommendations, smoking cessa...
Citation: Addiction Science & Clinical Practice 2022 17:1 -
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule
In the United States, methadone for opioid use disorder (OUD) is limited to highly regulated opioid treatment programs (OTPs), rendering it inaccessible to many patients. The “72-hour rule” allows non-OTP prov...
Citation: Addiction Science & Clinical Practice 2021 16:73 -
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis
In the United States, methadone for opioid use disorder (OUD) is highly regulated. Federal agencies announced guidelines in March 2020 allowing for relaxation of take-home methadone dispensing at opioid treatm...
Citation: Addiction Science & Clinical Practice 2021 16:72 -
Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report
Poppy seeds contain morphine and other opioid alkaloids and are commercially available in the United States. Users of poppy seed tea (PST) can consume several hundred morphine milligram equivalents per day, an...
Citation: Addiction Science & Clinical Practice 2021 16:71 -
A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
Patients with opioid use disorder (OUD) display an interindividual variability in their response to medications for opioid use disorder (MOUD). A genetic basis may explain the variability in this response. How...
Citation: Addiction Science & Clinical Practice 2021 16:70 -
The validation and reliability of a Japanese version of the Problematic Online Gaming Questionnaire (POGQ-J)
The Problematic Online Gaming Questionnaire (POGQ) is an 18-item self-rated measure designed to assess the degree of problematic online gaming. This study translated the POGQ into Japanese (POGQ-J) and examine...
Citation: Addiction Science & Clinical Practice 2021 16:69 -
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
The COVID-19 pandemic has exerted a significant toll on the lives of people who use opioids (PWUOs). At the same time, more flexible regulations around provision of opioid use disorder (OUD) services have led ...
Citation: Addiction Science & Clinical Practice 2021 16:68 -
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
The CHOICES study randomized participants with HIV and opioid use disorder (OUD) to HIV clinic-based extended-release naltrexone (XR-NTX), which requires complete cessation of opioid use, versus treatment-as-u...
Citation: Addiction Science & Clinical Practice 2021 16:67 -
Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use
The emergency department (ED) offers an important opportunity to identify patients with opioid use disorder (OUD) and initiate treatment. However, post-ED follow-up is challenging, and novel approaches to enha...
Citation: Addiction Science & Clinical Practice 2021 16:66 -
Alcohol dependence in a community sample of Aboriginal and Torres Strait Islander Australians: harms, getting help and awareness of local treatments
Few studies have examined links between current alcohol dependence and specific harms among Indigenous Australians. We investigated these associations as well as help seeking for drinking, awareness of local t...
Citation: Addiction Science & Clinical Practice 2021 16:65 -
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs
Medications for opioid use disorder such as opioid agonist treatment (OAT, including methadone, buprenorphine) are the gold standard intervention for opioid use disorder (OUD). Persons with OUD have high rates...
Citation: Addiction Science & Clinical Practice 2021 16:64 -
Addressing complex pharmacy consultations: methods used to develop a person-centred intervention to highlight alcohol within pharmacist reviews of medications
Alcohol is challenging to discuss, and patients may be reluctant to disclose drinking partly because of concern about being judged. This report presents an overview of the development of a medications review i...
Citation: Addiction Science & Clinical Practice 2021 16:63 -
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial
Opioid-related overdoses and harms have been declared a public health emergency in the United States, highlighting an urgent need to implement evidence-based treatments. Contingency management (CM) is one of t...
Citation: Addiction Science & Clinical Practice 2021 16:61 -
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review
Methamphetamine/amphetamine use has sharply increased among people with opioid use disorder (OUD). It is therefore important to understand whether and how use of these substances may impact receipt of, and out...
Citation: Addiction Science & Clinical Practice 2021 16:62 -
An Ethnographic study of unhealthy alcohol use in a Danish Emergency Department
Emergency Departments (EDs) are important arenas for the detection of unhealthy substance use. Screening, Brief Intervention, and Referral to Treatment (SBIRT) for unhealthy alcohol use has been used in some E...
Citation: Addiction Science & Clinical Practice 2021 16:60 -
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting
Urine drug screening (UDS) is commonly used as part of treatment for opioid use disorder (OUD), including treatment with buprenorphine-naloxone for OUD in a primary care setting. Very little is known about th...
Citation: Addiction Science & Clinical Practice 2021 16:59 -
Correction to: Reimagining brief interventions for alcohol: towards a paradigm fit for the twenty first century
Citation: Addiction Science & Clinical Practice 2021 16:58 -
Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study
Stimulant use has increased across the US, with concomitant opioid and methamphetamine use doubling between 2011 and 2017. Shifting patterns of polysubstance use have led to rising psychostimulant-involved dea...
Citation: Addiction Science & Clinical Practice 2021 16:57
Follow
Affiliated with
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
4.4 - 5-year Impact Factor
0.956 - SNIP (Source Normalized Impact per Paper)
1.166 - SJR (SCImago Journal Rank)2023 Speed
25 days submission to first editorial decision for all manuscripts (Median)
202 days submission to accept (Median)2023 Usage
755,413 downloads
622 Altmetric mentions
Archival content
Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.